Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-α secretion by THP-1 human macrophages

Free Radical Biology and Medicine

Volumn 23, Issue 4, 1997, Pages 658-667

  Girona, Josefa ^a   La Ville, Agnes E ^a   Heras, Mercedes ^a   Olivé, Sílvia ^a   Masana, Lluís ^a,b  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Facultat de Medicina   (Spain)

Author keywords

Aldehydes; HDL; HDL peroxidation; LDL; Lipid hydroperoxides; THP 1 monocytes macrophages; TNF

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; FOAM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIPID PEROXIDATION; MACROPHAGE; MONOCYTE; OXIDATION; PRIORITY JOURNAL;

ALDEHYDES; CELL LINE; HUMANS; KINETICS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; MACROPHAGES; OXIDATION-REDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030802815     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00061-0     Document Type: Article

References (43)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
2. Schmitz G., Kovacs E., Rothe G. Influence of lipoproteins on monocyte differentiation and activation. Atherosclerosis Rev. 25:1993;267-276.
3. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witzum J. L. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
4. Steinberg P., Witztum J. L. Lipoproteins and atherogenesis: Current concepts. JAMA. 264:1990;3047-3052.
5. Hoff H. F., O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler. Thromb. 11:1991;1209-1222.
6. Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells. J. Biol. Chem. 267:1992;218-225.
7. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
8. Steinbrecher U. P., Lougheed M., Zhang H. Biochemical basis of the receptor interaction and altered intracellular catabolism of oxidized LDL. Atherosclerosis Rev. 25:1993;247-257.
9. Witztum J. L. Role of oxidised low density lipoprotein in atherogenesis. Br. Heart J. 69:1993;12-18.
10. Ardlie N. G., Selley M. L., Simons L. A. Platelet activation by oxidatively modified lipoproteins. Atherosclerosis. 76:1989;117-124.
11. Frostegrd J., Wu R., Giscombe R., Holm G., Lefvert A. K., Nilsson J. Induction of T-cell Activation by oxidized low density lipoprotein. Arterioscler. Thromb. 12:1992;461-467.
12. Terkeltaub R., Banka C. L., Solan J., Santoro D., Brand K., Curtiss L. K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14:1994;47-53.
13. Brand K., Banka C.L., Mackman N., Terkeltaub R. A., Fan S. T., Curtiss L. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler. Thromb. 14:1994;790-797.
14. Hamilton T. A., Guoping M. A., Chisolm G. M. Oxidized low density lipoproteins suppresses the expression of Tumor Necrosis Factor-a mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:1990;2343-2350.
15. Jovinge S., Ares M. P. S., Kalling B., Nilsson J. Human Monocytes/macrophages release TNF- α in response to ox-LDL. Arterioscler. Thromb. Vasc. Biol. 16:1996;1573-1579.
16. Rao G. N., Alexander R. W., Runge M. S. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J. Clin. Invest. 96:1995;842-847.
17. Esterbauer H., Gebicki J., Puhl H., Jrgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Bio. Med. 13:1992;341-390.
18. Schmitz G., Lackner K. High density lipoproteins and atherosclerosis. Curr. Opin. Lipidol. 4:1993;392-400.
19. La Ville A. E., Sol R., Balanya J., Turner P. R., Masana L. In vitro oxidized HDL is recognised by the scavenger receptor of macrophages: Implications for its protective role in vivo. Atherosclerosis. 105:1994;179-189.
20. Morel D. W. Altered LDL and HDL function induced by lipid peroxidation. Atherosclerosis Rev. 25:1993;259-265.
21. Auwerx J. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 47:1991;22-30.
22. Patterson M. K. J. Measurement of growth and viability of cells in culture. Methods Enzymol. 58:1979;141-152.
23. Schumaker V. N., Puppione D. L. Sequential flotation ultracentrifugation. Methods Enzymol. 128:1986;155-170.
24. Yagi K. A. A simple flurimetric analysis for hydroperoxide in blood plasma. Biochem. Med. Metab. Biol. 15:1976;212-216.
25. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Com. 6:1989;67-75.
27. Esterbauer H., Cheeseman K. H. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 182:1990;407-421.
28. Nilsson J. Cytokines and smooth muscle cells in atherosclerosis. Cardivasc. Res. 27:1993;1184-1190.
29. Stiko A., Regnstrm J., Shah P. K., Cercek B., Nilsson J. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA syntesis. Arterioscler. Thromb. Vasc. Biol. 16:1996;194-200.
30. Thai S. F., Lewis J. G., Williams R. B., Johonson S. P., Adams D. O. Effects of oxidized LDL on momonuclear phagocytes:Iinhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolisis of tumor cells. J. Leukocyte Biol. 57:1995;427-433.
31. Ku G., Thomas C. E., Akeson A. L., Jackson R. L. Induction of interleukin 1beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267:1992;14183-14188.
32. Fong L. G., Fong T. A. T., Cooper A. D. Inhibition of lipopolysaccharide-induced interleukin- 1β mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid Res. 32:1991;1899-1910.
33. Ohlsson B. G., Englund M. C. O., Karlsson A. K., Knut-sen E., Erixon C., Skribeck H., Liu Y., Bondjers G., Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor- κB to DNA and subsequent expression of tumor necrosis factor- α and interleukin- 1α in macrophages. J. Clin. Invest. 98:1996;78-89.
34. Van Lenten B. J., Fogelman A. M., Haberland M. E., Edwards P. A. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 83:1986;2704-2708.
35. Thomas C. E., Jackson R. L., Ohlweiler D. F., Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J. Lipid Res. 35:1994;417-427.
36. Lipton B. A., Parthasarathary S., Ord V. A., Clinton S. K., Libby P., Rosenfeld M. E. Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells. J. Lipid Res. 36:1995;2232-2242.
37. Rosenfeld M. E., Khoo J. C., Miller E., Parthasarathy S., Palinski W., Witzum J. L. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesion degrade modified lipoproteins, promote oxidation of low density lipoproteins and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:1991;90-99.
38. Steinbrecher U. P., Lougheed M., Kwan W. C., Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein by products of fatty acid peroxidation. J. Biol. Chem. 264:1989;15216-15223.
39. Martelli A., Canonero R., Cavanna M., Ceradelli M., Marinari U. M. Cytotoxic and genotoxic effects of five n-alkanals in primary cultures of rat and human hepatocytes. Mutat. Res. 323:1994;121-126.
40. Haan L. H., Bosselaers I., Jongen W. M., Zwijsen R. M., Koeman J. H. Effect of lipids and aldehydes on gap-junctional intercellular communication between human smooth muscle cells. Carcinogenesis. 15:1994;253-256.
41. Chen C., Loo G. Inhibition of lecithin: Cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes. J. Biochem. Toxicol. 10:1995;121-128.
42. Van Lenten B. J., Fogelman A. M. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-a. J. Immunol. 148:1992;112-116.
43. Hsu H. Y., Nicholson A. C., Hajjar D. P. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor alpha is transcriptionally and post transcriptionally regulated. J. Biol. Chem. 271:1996;7767-7773.